KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Tax Provisions (2016 - 2025)

Boston Scientific (BSX) has disclosed Tax Provisions for 17 consecutive years, with $30.0 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 30.43% to $30.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $492.0 million through Dec 2025, up 12.84% year-over-year, with the annual reading at $493.0 million for FY2025, 13.07% up from the prior year.
  • Tax Provisions hit $30.0 million in Q4 2025 for Boston Scientific, down from $183.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $255.0 million in Q4 2022 to a low of -$37.0 million in Q2 2021.
  • Historically, Tax Provisions has averaged $90.0 million across 5 years, with a median of $91.5 million in 2022.
  • Biggest five-year swings in Tax Provisions: tumbled 233.33% in 2021 and later soared 2200.0% in 2024.
  • Year by year, Tax Provisions stood at $26.0 million in 2021, then skyrocketed by 880.77% to $255.0 million in 2022, then tumbled by 99.61% to $1.0 million in 2023, then skyrocketed by 2200.0% to $23.0 million in 2024, then soared by 30.43% to $30.0 million in 2025.
  • Business Quant data shows Tax Provisions for BSX at $30.0 million in Q4 2025, $183.0 million in Q3 2025, and $146.0 million in Q2 2025.